Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study
- 1 June 2007
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (6) , 1168-1177
- https://doi.org/10.1016/j.clinthera.2007.06.017
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHDEuropean Child & Adolescent Psychiatry, 2004
- Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled TrialPediatrics, 2004
- Comparison of Attention-Deficit/Hyperactivity Disorder Symptom Subtypes in Ukrainian SchoolchildrenJournal of the American Academy of Child & Adolescent Psychiatry, 2000
- Efficacy of Modafinil Compared to Dextroamphetamine for the Treatment of Attention Deficit Hyperactivity Disorder in AdultsJournal of Child and Adolescent Psychopharmacology, 2000
- Stimulant MedicationsJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- A Double-blind, Crossover Comparison of Methylphenidate and Placebo in Adults With Childhood-Onset Attention-Deficit Hyperactivity DisorderArchives of General Psychiatry, 1995
- Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- The Application of the Principle of Intention–to–Treat to the Analysis of Clinical TrialsDrug Information Journal, 1991
- Single‐Dose and Steady‐State Pharmacokinetics of Tomoxetine in Normal SubjectsThe Journal of Clinical Pharmacology, 1985
- Hyperactives as young adults: Past and current substance abuse and antisocial behavior.Australian and New Zealand Journal of Surgery, 1984